These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32572713)

  • 21. Self-selection for mammography screening according to use of hormone replacement therapy: A systematic literature review.
    Heinig M; Schwarz S; Haug U
    Cancer Epidemiol; 2021 Apr; 71(Pt A):101812. PubMed ID: 33608235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable?
    Sterns EE; Zee B
    Breast Cancer Res Treat; 2000 Jan; 59(2):125-32. PubMed ID: 10817347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case-control study of increased mammographic breast density response to hormone replacement therapy.
    Vachon CM; Sellers TA; Vierkant RA; Wu FF; Brandt KR
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1382-8. PubMed ID: 12433715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Change in risk of breast cancer after receiving hormone replacement therapy by considering effect-modifiers: a systematic review and dose-response meta-analysis of prospective studies.
    Wang K; Li F; Chen L; Lai YM; Zhang X; Li HY
    Oncotarget; 2017 Oct; 8(46):81109-81124. PubMed ID: 29113371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hormonal replacement therapy and breast cancer].
    This P
    Rev Prat; 2005 Feb; 55(4):377-82. PubMed ID: 15828615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density.
    Persson I; Thurfjell E; Holmberg L
    J Clin Oncol; 1997 Oct; 15(10):3201-7. PubMed ID: 9336356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens.
    Lundström E; Wilczek B; von Palffy Z; Söderqvist G; von Schoultz B
    Climacteric; 2001 Mar; 4(1):42-8. PubMed ID: 11379377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study.
    Rosenberg LU; Granath F; Dickman PW; Einarsdóttir K; Wedrén S; Persson I; Hall P
    Breast Cancer Res; 2008; 10(5):R78. PubMed ID: 18803850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
    Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
    Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hormone replacement therapy and breast cancer].
    Dobashi K
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):871-6. PubMed ID: 10396312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
    Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of mammographic breast density with menopausal status and postmenopausal hormone use in relation to the risk of aggressive breast cancer subtypes.
    Yaghjyan L; Tamimi RM; Bertrand KA; Scott CG; Jensen MR; Pankratz VS; Brandt K; Visscher D; Norman A; Couch F; Shepherd J; Fan B; Chen YY; Ma L; Beck AH; Cummings SR; Kerlikowske K; Vachon CM
    Breast Cancer Res Treat; 2017 Sep; 165(2):421-431. PubMed ID: 28624977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies.
    Verheul HA; Coelingh-Bennink HJ; Kenemans P; Atsma WJ; Burger CW; Eden JA; Hammar M; Marsden J; Purdie DW
    Maturitas; 2000 Jul; 36(1):1-17. PubMed ID: 10989237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An analysis of the effect of selection bias on the association of hormone replacement therapy and breast cancer risk.
    Csizmadi I; Friedenreich CM; Bryant HE; Courneya KS
    Chronic Dis Can; 2005; 26(2-3):73-9. PubMed ID: 16251013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits.
    Gordhandas S; Norquist BM; Pennington KP; Yung RL; Laya MB; Swisher EM
    Gynecol Oncol; 2019 Apr; 153(1):192-200. PubMed ID: 30661763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study.
    Lund E; Bakken K; Dumeaux V; Andersen V; Kumle M
    Int J Cancer; 2007 Aug; 121(3):645-8. PubMed ID: 17372914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
    Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Marchbanks PA; Coates RJ; Norman SA; Weiss LK; Ursin G; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Spirtas R
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1175-81. PubMed ID: 14652277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic review.
    Wang Y; Lewin N; Qaoud Y; Rajaee AN; Scheer AS
    Breast; 2018 Aug; 40():123-130. PubMed ID: 29763858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.